Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Common side effects include: Dizziness or lightheadedness Increased urination Nausea, vomiting, or diarrhea Headache Breast tenderness or enlargement (in men and women) Menstrual irregularities (in women) More serious, but less common, side effects include high potassium levels (hyperkalemia), kidney problems, and allergic reactions
For a full scientific overview of SLU-PP-332, see our research reference page: SLU-PP-332 Overview Bulk orders automatically save 20% on any 10+ vials (BAC excluded) Important Notice: This product is sold strictly for laboratory research purposes only
Nn dng bui sng v/hoc bui ti trc khi ng
The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin is released only when blood glucose levels are elevated, reducing hypoglycemia risk when used as monotherapy (though risk increases when combined with insulin or sulfonylureas)
Don't finish your meal before the timer goes off
